Form 4: TPAV LLC Distributes Traws Pharma Shares, Exiting 10% Ownership
SEC Form 4
TPAV, LLC distributed its holdings of Traws Pharma common stock and Series C preferred stock to its members, including Nikolay Savchuk, ceasing to be a 10% owner.
Summary
- On April 2, 2025, TPAV, LLC distributed all of its shares of Traws Pharma's common stock and Series C Non-Voting Convertible Preferred Stock to its members, including Nikolay Savchuk.
- This distribution was pro rata, and no consideration was paid.
- As a result, TPAV is no longer a 10% owner of Traws Pharma and will no longer be subject to Section 16 reporting requirements.
- Nikolay Savchuk, as a member of TPAV, received 170,710 shares of common stock and 638.1904 shares of Series C Preferred Stock directly.
- Savchuk will continue to be subject to Section 16 reporting requirements.
- The document also references a one-for-twenty-five reverse stock split that was effective on September 20, 2024.
- All share amounts reported are presented on an after-reverse stock split basis.
- Each share of Series C Preferred Stock is convertible into 400 shares of common stock, subject to a beneficial ownership limitation of 19.99%.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a change in ownership structure. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Future Outlook
TPAV, LLC will no longer be subject to Section 16 reporting requirements. Mr. Savchuk will continue to be subject to Section 16.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- Shareholders may see a shift in the ownership structure of the company.
- The distribution of shares may impact the trading volume and price of the stock.
Key Dates
| Date | Description |
|---|---|
| 2024-09-16 | Issuer's Board of Directors approved a one-for-twenty-five reverse stock split. |
| 2024-09-20 | Effective date of the one-for-twenty-five reverse stock split. |
| 2025-04-02 | TPAV, LLC disposed of all shares of Common Stock and Series C Preferred Stock through a pro rata distribution to its members. |
| 2025-04-08 | Date of signatures for the Form 4 filing. |
Keywords
Traws Pharma, TPAV LLC, Nikolay Savchuk, Form 4, Beneficial Ownership, Stock Distribution, Reverse Stock Split, Series C Preferred Stock, Section 16
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.